Autoantigen‐selected B cells are bystanders in spontaneous T cell‐driven experimental autoimmune hepatitis
暂无分享,去创建一个
J. Herkel | S. Weidemann | M. Binder | M. Preti | A. Carambia | C. Schultheiss | L. Schlott | David Lübbering | A. Lohse
[1] M. Gisslén,et al. COVID‐19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity , 2022, Journal of medical virology.
[2] M. Altfeld,et al. Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis. , 2022, Journal of hepatology.
[3] A. Spoorenberg,et al. B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis , 2021, International journal of molecular sciences.
[4] M. Manns,et al. Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration , 2021, Cells.
[5] J. Herkel,et al. Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver , 2021, JCI insight.
[6] J. Gommerman,et al. B cell depletion therapies in autoimmune disease: advances and mechanistic insights , 2020, Nature Reviews Drug Discovery.
[7] A. Lohse,et al. Next‐Generation Immunosequencing Reveals Pathological T‐Cell Architecture in Autoimmune Hepatitis , 2020, Hepatology.
[8] N. Pochet,et al. Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation. , 2020, Cell reports.
[9] J. Herkel,et al. Autoimmune hepatitis: Possible triggers, potential treatments. , 2020, Journal of hepatology.
[10] Tinghong Ye,et al. Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation , 2020, Cell Death & Disease.
[11] M. Manns,et al. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group , 2019, JHEP reports.
[12] C. Mack,et al. The Contribution of B Cells in Autoimmune Liver Diseases , 2019, Seminars in Liver Disease.
[13] J. Cyster,et al. B Cell Responses: Cell Interaction Dynamics and Decisions , 2019, Cell.
[14] S. Opat,et al. Anti-CD20 monoclonal antibodies: reviewing a revolution , 2018, Human vaccines & immunotherapeutics.
[15] M. Fujimoto,et al. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance , 2018, Science Advances.
[16] M. Manns,et al. Autoimmune hepatitis , 2018, Nature Reviews Disease Primers.
[17] Rohit Loomba,et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity , 2017, Nature.
[18] D. Kono,et al. The multiple pathways to autoimmunity , 2017, Nature Immunology.
[19] A. Verkman,et al. Mechanisms of Autoantibody-Induced Pathology , 2017, Front. Immunol..
[20] Donald W. Lee,et al. BRILIA: Integrated Tool for High-Throughput Annotation and Lineage Tree Assembly of B-Cell Repertoires , 2017, Front. Immunol..
[21] L. Kappos,et al. Cocapture of cognate and bystander antigens can activate autoreactive B cells , 2017, Proceedings of the National Academy of Sciences.
[22] D. Parker,et al. CD40L is transferred to antigen‐presenting B cells during delivery of T‐cell help , 2017, European journal of immunology.
[23] K. Abe,et al. Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis , 2016, SpringerPlus.
[24] F. Alvarez,et al. AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Depletion of B Cells Induces Remission of Autoimmune Hepatitis in Mice Through Reduced Antigen Presentation and Help to T Cells , 2015 .
[25] Y. Chu,et al. B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice , 2015, Hepatology.
[26] A. Radbruch,et al. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice , 2015, PloS one.
[27] Ping Shen,et al. Antibody-independent functions of B cells: a focus on cytokines , 2015, Nature Reviews Immunology.
[28] Mikhail Shugay,et al. MiXCR: software for comprehensive adaptive immunity profiling , 2015, Nature Methods.
[29] E. Rosser,et al. Regulatory B cells: origin, phenotype, and function. , 2015, Immunity.
[30] M. Manns,et al. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. , 2014, Journal of hepatology.
[31] Yanfang Jiang,et al. Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[32] R. Sobel,et al. MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies , 2013, The Journal of experimental medicine.
[33] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[34] D. Gray,et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells , 2012, The Journal of experimental medicine.
[35] G. Ahlenstiel,et al. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. , 2008, Gastroenterology.
[36] Kerstin Amann,et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis , 2008, Nature Medicine.
[37] R. Tisch,et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice , 2007, Proceedings of the National Academy of Sciences.
[38] M. Hussain,et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. , 2006, Gastroenterology.
[39] M. Shlomchik,et al. Antigen-Specific B Cells Are Required as APCs and Autoantibody-Producing Cells for Induction of Severe Autoimmune Arthritis1 , 2005, The Journal of Immunology.
[40] J. Monroe,et al. Incomplete Activation of CD4 T Cells by Antigen-Presenting Transitional Immature B Cells: Implications for Peripheral B and T Cell Responsiveness1 , 2003, The Journal of Immunology.
[41] G. Bellomo,et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane , 2000, Gut.
[42] R. Tisch,et al. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. , 1998, Journal of immunology.
[43] G. Gerken,et al. Autoreactive CD4+ LKM‐specific and anticlonotypic T‐cell responses in LKM‐1 antibody‐positive autoimmune hepatitis , 1996, Hepatology.
[44] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[45] C. Coffin,et al. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[46] Gábor Csárdi,et al. The igraph software package for complex network research , 2006 .